Articles by Sy Mukherjee | Fortune

Skip to Content

SIGN IN

Newsletters
Biogen doubles down on Alzheimer's with massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Newsletters
Can Gilead tame the coronavirus?
By
Sy Mukherjee
February 27, 2020
Health
Gilead’s coronavirus treatment is barreling its way into new clinical trials
By
Sy Mukherjee
February 27, 2020
Newsletters
Apple continues its health care push with Johnson & Johnson heart study
By
Sy Mukherjee
February 26, 2020
Health
The first U.S. trial for a coronavirus treatment has started
By
Sy Mukherjee
February 25, 2020
Newsletters
How AI actually works when it comes to discovering new antibiotics
By
Sy Mukherjee
February 25, 2020
Health
Scientists are turning to A.I. to discover new antibiotics that can fight superbugs
By
Sy Mukherjee
February 25, 2020
Newsletters
Sanofi readies a new drug supply firm in Europe
By
Sy Mukherjee
February 24, 2020
Health
Sanofi is set to launch a new European drug manufacturing firm
By
Sy Mukherjee
February 24, 2020
Newsletters
Smoking, coronavirus, and the deaths of Chinese men
By
Sy Mukherjee
February 19, 2020
Health
China’s high smoking rate may be exacerbating the coronavirus outbreak
By
Sy Mukherjee
February 19, 2020
Health
Shelved SARS treatments could help with the new coronavirus
By
Sy Mukherjee
February 18, 2020
Newsletters
When innovation doesn't equal improvement
By
Sy Mukherjee
February 14, 2020
Health
AstraZeneca stock falls as coronavirus uncertainty mars 2020 outlook
By
Sy Mukherjee
February 14, 2020
Newsletters
Telehealth startup Ro launches a 'digital health clinic for men'
By
Sy Mukherjee
February 14, 2020

1 - 15 of 1,629 results

1 - 15 of 1,629 results

© 2019 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy (Your California Privacy Rights) | CCPA Do Not Sell My Information
Fortune may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions. | EU Data Subject Requests